Old Web
English
Sign In
Acemap
>
authorDetail
>
R.B. Warren
R.B. Warren
Salford Royal NHS Foundation Trust
Medicine
Psoriasis
Internal medicine
Clinical trial
Psoriasis Area and Severity Index
4
Papers
13
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Editorial: fixed-dose combination calcipotriol/betamethasone dipropionate foam in the treatment of patients with psoriasis.
2021
Journal of The European Academy of Dermatology and Venereology
Mark Lebwohl
R.B. Warren
Show All
Source
Cite
Save
Citations (0)
Network meta-analysis of biologic treatments for psoriasis using absolute Psoriasis Area and Severity Index (PASI) values ≤1, 2, 3 or 5 derived from a statistical conversion method.
2021
Journal of The European Academy of Dermatology and Venereology
Ulrich Mrowietz
R.B. Warren
Craig L. Leonardi
Daniel Saure
Helmut Petto
S. Hartz
Martin Dossenbach
Kristian Reich
Show All
Source
Cite
Save
Citations (3)
Five-year efficacy and safety of tildrakizumab in patients with moderate to severe psoriasis who respond at week 28: pooled analyses of two randomised phase 3 clinical trials (reSURFACE 1 and reSURFACE 2).
2021
British Journal of Dermatology
Diamant Thaçi
Stefano Piaserico
R.B. Warren
Aditya K. Gupta
Wendy Cantrell
Z. Draelos
Peter Foley
Atsuyuki Igarashi
Richard G. Langley
A. Asahina
M. Young
M Falques
Ignasi Pau-Charles
A.M. Mendelsohn
Stephen J. Rozzo
Kristian Reich
Show All
Source
Cite
Save
Citations (7)
1